93 related articles for article (PubMed ID: 29773319)
1. Harnessing Nanotechnology: Emerging Strategies for Multiple Myeloma Therapy.
Yang M; Chen Y; Zhu L; You L; Tong H; Meng H; Sheng J; Jin J
Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38254683
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticles in Gastrooncology.
Jefremow A; Neurath MF
Visc Med; 2020 Apr; 36(2):88-94. PubMed ID: 32355665
[TBL] [Abstract][Full Text] [Related]
3. Extraordinary Progress in the Treatment of Multiple Myeloma: Is a Cure on the Horizon?
Bergsagel PL
Hematol Oncol Clin North Am; 2024 Apr; 38(2):xiii-xv. PubMed ID: 38171938
[No Abstract] [Full Text] [Related]
4. Toward personalized treatment in multiple myeloma based on molecular characteristics.
Pawlyn C; Davies FE
Blood; 2019 Feb; 133(7):660-675. PubMed ID: 30587529
[TBL] [Abstract][Full Text] [Related]
5. Novel biomarkers in multiple myeloma.
Levin A; Hari P; Dhakal B
Transl Res; 2018 Nov; 201():49-59. PubMed ID: 30301522
[TBL] [Abstract][Full Text] [Related]
6. Multiple myeloma: 2020 update on diagnosis, risk-stratification and management.
Rajkumar SV
Am J Hematol; 2020 May; 95(5):548-567. PubMed ID: 32212178
[TBL] [Abstract][Full Text] [Related]
7. Multiple myeloma: Every year a new standard?
Rajkumar SV
Hematol Oncol; 2019 Jun; 37 Suppl 1(Suppl 1):62-65. PubMed ID: 31187526
[TBL] [Abstract][Full Text] [Related]
8. Multiple Myeloma: Clinical Updates From the American Society of Hematology Annual Meeting 2018.
Terpos E; Ntanasis-Stathopoulos I;
Clin Lymphoma Myeloma Leuk; 2019 Jul; 19(7):e324-e336. PubMed ID: 31076371
[TBL] [Abstract][Full Text] [Related]
9. The impact of NF-κB signaling on pathogenesis and current treatment strategies in multiple myeloma.
Vrábel D; Pour L; Ševčíková S
Blood Rev; 2019 Mar; 34():56-66. PubMed ID: 30501907
[TBL] [Abstract][Full Text] [Related]
10. Navigating the treatment landscape in multiple myeloma: which combinations to use and when?
Goldschmidt H; Ashcroft J; Szabo Z; Garderet L
Ann Hematol; 2019 Jan; 98(1):1-18. PubMed ID: 30470875
[TBL] [Abstract][Full Text] [Related]
11. Targeted Lymphoma Therapy Using a Gold Nanoframework-Based Drug Delivery System.
Bariana M; Zhang B; Sun J; Wang W; Wang J; Cassella E; Myint F; Anuncio SA; Ouk S; Liou HC; Tan M; Wang H; Zakrzewski JL
ACS Appl Mater Interfaces; 2023 Feb; 15(5):6312-6325. PubMed ID: 36701696
[TBL] [Abstract][Full Text] [Related]
12. Development and application of nanomaterials, nanotechnology and nanomedicine for treating hematological malignancies.
Li J; Wang Q; Han Y; Jiang L; Lu S; Wang B; Qian W; Zhu M; Huang H; Qian P
J Hematol Oncol; 2023 Jun; 16(1):65. PubMed ID: 37353849
[TBL] [Abstract][Full Text] [Related]
13. The MTT Assay: A Method for Error Minimization and Interpretation in Measuring Cytotoxicity and Estimating Cell Viability.
Ghasemi M; Liang S; Luu QM; Kempson I
Methods Mol Biol; 2023; 2644():15-33. PubMed ID: 37142913
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis and treatment of multiple myeloma.
Yang P; Qu Y; Wang M; Chu B; Chen W; Zheng Y; Niu T; Qian Z
MedComm (2020); 2022 Jun; 3(2):e146. PubMed ID: 35665368
[TBL] [Abstract][Full Text] [Related]
15. Tumor microenvironment-targeted nanoparticles loaded with bortezomib and ROCK inhibitor improve efficacy in multiple myeloma.
Federico C; Alhallak K; Sun J; Duncan K; Azab F; Sudlow GP; de la Puente P; Muz B; Kapoor V; Zhang L; Yuan F; Markovic M; Kotsybar J; Wasden K; Guenthner N; Gurley S; King J; Kohnen D; Salama NN; Thotala D; Hallahan DE; Vij R; DiPersio JF; Achilefu S; Azab AK
Nat Commun; 2020 Nov; 11(1):6037. PubMed ID: 33247158
[TBL] [Abstract][Full Text] [Related]
16. Recent Advances in Nanotherapeutics for Multiple Myeloma.
Iannazzo D; Ettari R; Giofrè S; Eid AH; Bitto A
Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33120945
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA MALAT1 facilitates the tumorigenesis, invasion and glycolysis of multiple myeloma via miR-1271-5p/SOX13 axis.
Liu N; Feng S; Li H; Chen X; Bai S; Liu Y
J Cancer Res Clin Oncol; 2020 Feb; 146(2):367-379. PubMed ID: 31953613
[TBL] [Abstract][Full Text] [Related]
18. Advancements in Nanomedicine for Multiple Myeloma.
Detappe A; Bustoros M; Mouhieddine TH; Ghoroghchian PP
Trends Mol Med; 2018 Jun; 24(6):560-574. PubMed ID: 29773319
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
